It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Bioaccumulation and trophodynamics of the antidepressants sertraline and fluoxetine in laboratory-constructed, 3-level aquatic food chains.
https://arctichealth.org/en/permalink/ahliterature283975
Source
Environ Toxicol Chem. 2017 Apr;36(4):1029-1037
Publication Type
Article
Date
Apr-2017
More detail
Author
Marja L Boström
Gustaf Ugge
Jan Åke Jönsson
Olof Berglund
Source
Environ Toxicol Chem. 2017 Apr;36(4):1029-1037
Date
Apr-2017
Language
English
Publication Type
Article
Keywords
Animals
Antidepressive Agents - analysis - metabolism
Aquatic Organisms - metabolism
Fluoxetine - analysis - metabolism
Food chain
Models, Theoretical
Sertraline - analysis - metabolism
Sweden
Water Pollutants, Chemical - analysis - metabolism
Abstract
Although reports of pharmaceutical bioconcentration in aquatic organisms are increasing, less is known about trophic transfer in aquatic food webs. The bioaccumulation and trophodynamics of sertraline and fluoxetine, 2 selective serotonin reuptake inhibitors (SSRIs) frequently detected in aquatic environments, were tested by exposing constructed aquatic food chains to SSRIs under controlled laboratory conditions. Both of these ionizable, weak base pharmaceuticals showed lower bioaccumulation factors (BAFs) with increasing trophic level (i.e., no biomagnifications) in 2 3-level food chains (Acer platanoides, fed to Asellus aquaticus, in turn fed to Notonecta glauca or Pungitius pungitius). Mean sertraline BAFs in A. platanoides, A. aquaticus, N. glauca, and P. pungitus were 2200?L/kg, 360?L/kg, 26?L/kg, and 49?L/kg, respectively, and mean fluoxetine BAFs 1300?L/kg, 110?L/kg, 11?L/kg, and 41?L/kg, respectively. The weak influence of diet was further demonstrated by measured BAFs being equal to or lower than measured bioconcentration factors (BCFs). Organism lipid content was not positively correlated with BAFs, suggesting that other processes are driving interspecific differences in SSRI bioaccumulation. The empirically derived parameter values were introduced into a proposed bioaccumulation model, and a poor correlation was found between modeled and empirical BAFs (predicted r(2) ?=?-0.63). In conclusion, the apparent lack of biomagnification of these ionizable pharmaceuticals suggests that environmental concern should not necessarily focus only on higher trophic levels, but also on species showing high BCFs at any trophic level. Environ Toxicol Chem 2017;36:1029-1037. © 2016 SETAC.
PubMed ID
27696515
View in PubMed
Less detail
Permalink